IGEA Pharma
  • Company
    • Board of directors
    • Management
  • Products
    • Health-tech Area
    • Med-tech Area
  • Investor Relations
    • Corporate Governance
    • Financial Reports
    • Information for shareholders
    • Press releases/News
    • Corporate Calendar
    • Corporate information
  • Contacts
  • MENU

Month: April 2020

IGEA Pharma supplies COVID-19 antibody-based test in the US

6 April 2020

Hoofddorp, the Netherlands, 6 April 2020. IGEA Pharma (SIX: IGPH) today announced to starting supply of a COVID-19 antibody test following an agreement signed with a PRC independent SARS-CoV-2 IgM/IgG test developer and manufacturer.

Continue reading →

Archives

  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • December 2018

IGEA Pharma Logo

Siriusdreef, 17

2132 WT, Hoofddorp, Netherlands

Tel: +31 23 568 94 94

Email: info@igeapharma.nl

Send Message

    Privacy Statement | Copyright © 2018 All Rights Reserved IGEA Pharma B.V.
    • Company
      • Board of directors
      • Management
    • Products
      • Health-tech Area
      • Med-tech Area
    • Investor Relations
      • Corporate Governance
      • Financial Reports
      • Information for shareholders
      • Press releases/News
      • Corporate Calendar
      • Corporate information
    • Contacts
    IGEA Pharma
    • Company
      • Board of directors
      • Management
    • Products
      • Health-tech Area
      • Med-tech Area
    • Investor Relations
      • Corporate Governance
      • Financial Reports
      • Information for shareholders
      • Press releases/News
      • Corporate Calendar
      • Corporate information
    • Contacts
    IGEA Pharma
    By continuing to use the site, you agree to the use of cookies, more information.